Compugen Ltd (NAS:CGEN)
$ 1.57 -0.06 (-3.68%) Market Cap: 141.45 Mil Enterprise Value: 31.69 Mil PE Ratio: 52.62 PB Ratio: 2.33 GF Score: 53/100

Compugen Ltd at Evercore ISI HealthCONx Conference Transcript

Dec 01, 2020 / 02:40PM GMT
Release Date Price: $12.88 (+0.31%)
Jonathan Miller
Evercore ISI Institutional Equities, Research Division - Associate

Hello, everybody. Welcome to our fireside chat with Compugen. Thank you to the company's management team for joining us. It's a quick chat today. So I'd love to jump straight into discussion here.

Questions & Answers

Jonathan Miller
Evercore ISI Institutional Equities, Research Division - Associate

Computational drug discovery has a bad reputation, a lot of times. Tell us a little bit about how Compugen's approach is different?

Anat Cohen;Dayag
Compugen Ltd. - CEO, President & Director

Yes. Thank you, Jonathan. And I can see why you're saying that. I think that in the last 2 years, it is gaining more momentum and attention. Compugen has a long history with respect to computational discovery. Actually, we've been for 20 years, computational discovery company, and then we moved to use our own computational predictions for the discovery of drug targets for the development of first-in-class drugs. The way

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot